Evidence map›Paper›PMID 38994745›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2024

Tau-mediated synaptic dysfunction is coupled with HCN channelopathy.

Despoina Goniotaki, Francesco Tamagnini, Luca Biasetti, Svenja-Lotta Rumpf, Claire Troakes, Saskia J Pollack, Shalom Ukwesa, Haoyue Sun, Igor Kraev, Louise C Serpell and 3 more

Abstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Proteomic analysis links truncated tau to lysosome motility, autophagy, and endo-lysosomal dysfunction.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Tau-mediated synaptic dysfunction is coupled with HCN channelopathy.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Despoina GoniotakiDepartment of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology & Neuroscience, Maurice Wohl Clinical Neuroscience Institute, King's College London, London, UK.ORCID 0000-0003-2120-8858
Francesco TamagniniDepartment of Pharmacy, School of Chemistry, Food and Pharmacy, University of Reading, Reading, UK.
Luca BiasettiSussex Neuroscience, School of Life Sciences, University of Sussex, Brighton, UK.
Svenja-Lotta RumpfDepartment of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology & Neuroscience, Maurice Wohl Clinical Neuroscience Institute, King's College London, London, UK.
Claire TroakesDepartment of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology & Neuroscience, Maurice Wohl Clinical Neuroscience Institute, King's College London, London, UK.
Saskia J PollackDepartment of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology & Neuroscience, Maurice Wohl Clinical Neuroscience Institute, King's College London, London, UK.
Shalom UkwesaDepartment of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology & Neuroscience, Maurice Wohl Clinical Neuroscience Institute, King's College London, London, UK.
Haoyue SunDepartment of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology & Neuroscience, Maurice Wohl Clinical Neuroscience Institute, King's College London, London, UK.
Igor KraevElectron Microscopy Suite, STEM Faculty, The Open University, Milton Keynes, UK.
Louise C SerpellSussex Neuroscience, School of Life Sciences, University of Sussex, Brighton, UK.
Wendy NobleDepartment of Clinical and Biomedical Sciences, University of Exeter, Exeter, UK.
Kevin StarasSussex Neuroscience, School of Life Sciences, University of Sussex, Brighton, UK.
Diane P HangerDepartment of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology & Neuroscience, Maurice Wohl Clinical Neuroscience Institute, King's College London, London, UK.ORCID 0000-0002-3044-9816

Funding

Alzheimer's Research UKAlzheimer's SocietyBiotechnology and Biological Sciences Research Council BB/K019015/1Biotechnology and Biological Sciences Research Council BB/S00310X/1Wellcome Trust
6 · The paper itself

Abstract

introductionIn tauopathies, altered tau processing correlates with impairments in synaptic density and function. Changes in hyperpolarization-activated cyclic nucleotide-gated (HCN) channels contribute to disease-associated abnormalities in multiple neurodegenerative diseases.

methodsTo investigate the link between tau and HCN channels, we performed histological, biochemical, ultrastructural, and functional analyses of hippocampal tissues from Alzheimer's disease (AD), age-matched controls, Tau35 mice, and/or Tau35 primary hippocampal neurons.

resultsExpression of specific HCN channels is elevated in post mortem AD hippocampus. Tau35 mice develop progressive abnormalities including increased phosphorylated tau, enhanced HCN channel expression, decreased dendritic branching, reduced synapse density, and vesicle clustering defects. Tau35 primary neurons show increased HCN channel expression enhanced hyperpolarization-induced membrane voltage "sag" and changes in the frequency and kinetics of spontaneous excitatory postsynaptic currents. DISCUSSION: Our findings are consistent with a model in which pathological changes in tauopathies impact HCN channels to drive network-wide structural and functional synaptic deficits. HIGHLIGHTS: Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels are functionally linked to the development of tauopathy. Expression of specific HCN channels is elevated in the hippocampus in Alzheimer's disease and the Tau35 mouse model of tauopathy. Increased expression of HCN channels in Tau35 mice is accompanied by hyperpolarization-induced membrane voltage "sag" demonstrating a detrimental effect of tau abnormalities on HCN channel function. Tau35 expression alters synaptic organization, causing a loosened vesicle clustering phenotype in Tau35 mice.

Indexed as

Alzheimer DiseaseHippocampusHyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsMice, TransgenicSynapsestau ProteinsAgedAnimalsChannelopathiesDisease Models, AnimalFemaleHumansMaleMiceNeuronsTauopathiesHyperpolarization-Activated Cyclic Nucleotide-Gated Channelstau Proteinsdementiahyperpolarization‐activated cyclic nucleotide‐gated channelsneurodegenerationsag voltagesynapsestauopathies

Identifiers

PMID38994745
PMCPMC11350046

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.